|
Profile: New Jersey Nanotechnology Consortium
There's little doubt about the pervasiveness of nanotechnology
development - it represents the place in history where the classic
disciplines of chemistry, physics and biology converge, and has
become a dominant element of research in virtually every scientific
community around the globe. Even as researchers continue to learn
about the behavior of complex structures at molecular dimensions,
early nanotechnology developments can deliver better electronics,
communications and medical treatments today.
The New Jersey Nanotechnology Consortium (NJNC) provides rapid
and cost-effective access to world-class nanotechnology research
and development services, allowing breakthrough nanotechnology-driven
innovations - from minimally invasive surgical tools and genechips
for early disease diagnosis to pressure, temperature and bio sensors
for disease prevention tolens arrays and waveguides for communication
breakthroughs - to be commercially developed within the next few
years. These types of innovations will help drive the nanotechnology
industry into a forecasted $1 trillion business in the next 10 to
15 years, according to the National Science Foundation.
A private-public endeavor, NJNC was launched in early 2003 by Lucent
Technologies, the state of New Jersey and the New Jersey Institute
of Technology. NJNC is headquartered at the New Jersey Nanotechnology
Laboratory in the world-renowned Bell Labs in Murray Hill, N.J.,
located close to New Jersey's leading electronics and pharmaceutical
companies. By combining the leading-edge fabrication capabilities
of this lab with New Jersey's academic research institutions and
universities, NJNC is able to carry out basic and applied nanotechnology
research while stressing the unique capability of bringing nanotechnology
ideas from concept into commercialization.
With a highly experienced research team, NJNC offers design, prototyping
and fabrication capabilities to member companies and the wider nanotechnology
community, including companies in the pharmaceutical, biotechnology,
materials, optical/photonics, defense/aerospace and semiconductor
markets. The consortium also supports development of the nanotechnology
industry by educating the next generation of scientists, spearheading
joint research and driving nanotechnology roadmap programs.
|